
NILOTINIB 200 mg (Ninlib) is a prescription targeted anticancer medicine used to treat adults and children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML). It belongs to a class of medicines called tyrosine kinase inhibitors (TKIs) and helps slow or stop the growth of leukaemia cells. It should be taken exactly as prescribed under the supervision of an oncologist.
| Generic name | NILOTINIB |
| Strength | 200 mg |
| Manufacturer | Hetero |
| Package size | 30 Capsules |
| Used for | Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Nilotinib 200 mg works by blocking BCR-ABL tyrosine kinase, an abnormal protein produced by the Philadelphia chromosome. This protein promotes the uncontrolled growth of leukaemia cells. By inhibiting its activity, nilotinib helps slow or stop the growth and multiplication of abnormal blood cells.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.